This inventor holds 2 USPTO granted patents. Top assignee: Medimmune Limited. Active years: 2012-2013.
Company Filing History:
Years Active: 2012-2013
Title: Neil Michaud: Innovator in Targeted Binding Agents
Introduction
Neil Michaud is a prominent inventor based in Waltham, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of targeted binding agents. With a total of 2 patents to his name, Michaud's work focuses on innovative solutions for medical diagnostics and treatment.
Latest Patents
Michaud's latest patents include groundbreaking inventions related to targeted binding agents directed to the human sonic hedgehog homolog (Shh). These inventions involve fully human monoclonal antibodies that target Shh, which is crucial in the treatment of diseases associated with its activity and overproduction. The described targeted binding agents are not only useful for therapeutic purposes but also serve as valuable diagnostic tools.
Career Highlights
Neil Michaud is currently associated with MedImmune Limited, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on treating various medical conditions linked to Shh.
Collaborations
Michaud collaborates with notable colleagues, including David Jenkins and Naomi Laing, who contribute to his innovative projects and research initiatives.
Conclusion
Neil Michaud's contributions to the field of biotechnology through his patents and collaborations highlight his role as a key innovator. His work on targeted binding agents has the potential to transform medical diagnostics and treatment strategies.